Bills · 118th Congress · Government Operations and Politics

Preventing the Financing of Illegal Synthetic Drugs Act

Where it stands

  1. Introduced2/17/23
  2. Passed HousePassed 5/22/23
  3. SenatePassed 7/23/24
  4. PresidentSigned 9/13/24
  5. LawPublic Law 118-79

Passed the House 402–2 on May 22, 2023 (Roll Call 228 →). Passed the Senate by unanimous consent on July 23, 2024. Became Public Law 118-79 on September 13, 2024.

Set your address to see how your representatives voted.

Roll calls on this bill

Votes on passage
HouseOn Motion to Suspend the Rules and Pass, as Amended · 5/22/23Suspension of the rulesA fast-track House procedure, usually for measures expected to have broad support. Debate is limited to 40 minutes, no amendments can be offered, and it needs a two-thirds vote of members voting — not a simple majority. A yes vote passes the bill. “As amended” means changes written into the motion itself are included.Rules of the House, Rule XV, clause 1 ↗
Passed
  • Democratic194 Yea · 0 Nay · 19 Not voting
  • Republican208 Yea · 2 Nay · 11 Not voting
  • Independent / Other0 Yea · 0 Nay · 0 Not voting
Official summary (CRS)

Preventing the Financing of Illegal Synthetic Drugs Act

This bill requires the Government Accountability Office to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.

Full text on congress.gov ↗
Sponsor
Rep. Monica De La Cruz ( Republican · TX-15)
Cosponsors
8
Introduced
2/17/23
Policy area
Government Operations and Politics

What happens next

Became Public Law 118-79.

All actions (25)
  1. 2/17/23Introduced in House
  2. 2/17/23Referred to the Committee on Financial Services, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  3. 2/24/23Referred to the Subcommittee on Health.
  4. 2/28/23Committee Consideration and Mark-up Session Held.
  5. 2/28/23Ordered to be Reported in the Nature of a Substitute (Amended) by Voice Vote.
  6. 5/22/23Reported (Amended) by the Committee on Financial Services. H. Rept. 118-75, Part I.
  7. 5/22/23Committee on the Judiciary discharged.
  8. 5/22/23Committee on Energy and Commerce discharged.
  9. 5/22/23Placed on the Union Calendar, Calendar No. 55.
  10. 5/22/23Mr. Luetkemeyer moved to suspend the rules and pass the bill, as amended.
  11. 5/22/23Considered under suspension of the rules. (consideration: CR H2469-2471)
  12. 5/22/23DEBATE - The House proceeded with forty minutes of debate on H.R. 1076.
  13. 5/22/23At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  14. 5/22/23Considered as unfinished business. (consideration: CR H2483)
  15. 5/22/23Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 2 (Roll no. 228). (text: CR H2469)
  16. 5/22/23On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 2 (Roll no. 228). (text: CR H2469)
  17. 5/22/23Motion to reconsider laid on the table Agreed to without objection.
  18. 5/30/23Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
  19. 7/23/24Senate Committee on Banking, Housing, and Urban Affairs discharged by Unanimous Consent.
  20. 7/23/24Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
  21. 7/23/24Passed Senate without amendment by Unanimous Consent. (consideration: CR S5319; text: CR S5319)
  22. 7/24/24Message on Senate action sent to the House.
  23. 9/11/24Presented to President.
  24. 9/13/24Signed by President.
  25. 9/13/24Became Public Law No: 118-79.